Imagion Biosystems Limited (ASX:IBX)
0.0160
-0.0020 (-11.11%)
Jun 5, 2026, 4:10 PM AEST
Imagion Biosystems Market Cap
Imagion Biosystems has a market cap or net worth of 7.85 million as of June 5, 2026. Its market cap has increased by 199.89% in one year.
Market Cap
7.85M
Enterprise Value
8.69M
Revenue
73.03K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since June 22, 2017, Imagion Biosystems's market cap has decreased from 32.65M to 7.85M, a decrease of -75.96%. That is a compound annual growth rate of -14.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 7.85M | -35.41% |
| Dec 31, 2025 | 12.15M | 162.45% |
| Dec 31, 2024 | 4.63M | -60.04% |
| Dec 29, 2023 | 11.59M | -56.93% |
| Dec 30, 2022 | 26.91M | -68.41% |
| Dec 31, 2021 | 85.20M | -41.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 384.10M |
| Monash IVF Group | 270.80M |
| Healius | 235.99M |
| Cryosite | 51.74M |
| INOVIQ | 47.86M |
| Microba Life Sciences | 38.36M |
| Rhythm Biosciences | 37.16M |
| BCAL Diagnostics | 27.28M |